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A nove!, mitogen-activated nuclear 
kmase 1s related to a Drosophda 
developmental regulator 
Gerald V. Denis  and Michael  R. Green 1 
Howard Hughes Medical Institute, Program in Molecular Medicine, University of Massachusetts Medical Center, Worcester, 
Massachusetts 01605 USA 
Although the ultimate targets of many signal transduction pathways are nuclear transcription factors, the vast 
majority of known protein kinases are cytosolic. Here, we report on a novel human kinase that is present 
exclusively in the nucleus. Kinase activity is increased upon cellular proliferation and is markedly elevated in 
patients with acute and chronic lymphocytic leukemias. We have identified a human gene that encodes this 
nuclear kinase and find that it is closely related to Drosophila female sterile homeotic {[sh), a developmental 
regulator with no known biochemical activity. Collectively, these r sults suggest hat this nuclear kinase is a 
component of a signal transduction pathway that plays a role in Drosophila development and human growth 
control. 
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A variety of extracellular signals can regulate the tran- 
scriptional activity of particular structural genes. Spe- 
cific nuclear-localized transcription factors are believed 
to be the ultimate targets of diverse~ signal transduction 
pathways (for reviews, see Hunter and Karin 1992; Jack- 
son 1992; Karin 1994). Two mechanisms have been de- 
scribed by which signals that regulate transcription 
reach the nucleus. In the first mechanism, in response to 
an appropriate signal, the transcription factor itself 
translocates from the cytosol to the nucleus. The proto- 
type transcription factor that uses this mechanism is 
NF-KB (Baeuerle and Baltimore 1988a, b), but other exam- 
ples include members of the STAT family (Darnell et al. 
1994), SV40 T antigen (Rihs et al. 1991), SWI5 (Moll et al. 
1991), Dorsal (Rushlow and Warrior 1992), v-Jun (Chida 
and Vogt 1992), ISGF3 (Kilgour and Anderson 1994), ste- 
roid hormone receptors (Kuiper and Brinkmann 1994), 
and NFAT (Liu 1993) (for review, see Whiteside and 
Goodbourn 1993). A second mechanism involves the nu- 
clear translocation of a cytosolic kinase, which in some 
cases directly phosphorylates the nuclear transcription 
factor target. For example, nuclear forms of protein ki- 
nase A (Nigg et al. 1985), protein kinase C (Leach et al. 
1989), p42 mapk and p44 mapk (MAP) kinases (Lenormand 
et al. 1993), and ribosomal $6 (RSK) kinase (Chen et al. 
1992) can be detected after mitogenic stimulation. 
It remains possible, however, that there are kinases 
that are downstream targets of cytosolic signaling path- 
ways but that are principally nuclear in localization. Lit- 
~Corresponding author. 
tle is known about such nuclear kinases, although some 
candidates include the c-Abl protein tyrosine kinase 
(Kipreos and Wang 1992), a DNA-dependent protein ki- 
nase (Jackson et al. 1990; Finnie et al. 1993), and a cell 
cycle-dependent complex containing p33 cdk2 kinase (De- 
voto et al. 1992; Faha et al. 1992). Furthermore, kinases 
that phosphorylate he carboxy-terminal domain (CTD} 
of RNA polymerase II, including the general transcrip- 
tion factor TFUH, have been characterized {Feaver et al. 
1991; Lu et al. 1992). However, a role for these kinases in 
signal transduction has not been established. 
In this paper we describe a novel nuclear kinase that 
has significant homology with fsh, a Drosophila protein 
known to be important in embryonic pattern formation 
(Haynes et al. 1989). The autophosphorylation activity of 
this kinase was correlated with cellular proliferation a d 
was elevated in patients with acute and chronic lympho- 
cytic leukemias. 
Results 
Identification of a 90-kD nuclear kinase 
To identify nuclear kinases, polypeptides in HeLa nu- 
clear or cytosolic extracts were separated by polyacryl- 
amide gel electrophoresis (SDS-PAGE), electroblotted to
nitrocellulose, denatured, renatured, and incubated with 
[~/-a2P]ATP. This assay detects autologous phosphoryla- 
tion, which is frequently correlated with kinase autoac- 
tivation (Hunter 1987). Figure 1 shows that one major 
and several minor polypeptides were autophosphory- 
late& The major multiplet, which had an apparent mo- 
bility of -90 kD, was present in nuclear extract but ab- 
sent from cytosolic extract. Several experiments suggest 
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from other kinases described to date (Pearson and Kemp 
1991 and references therein). 
The results of these peptide phosphorylation experi- 
ments suggested that the 90-kD nuclear kinase used 
serine and threonine as phosphoacceptors. To confirm 
this supposition, we performed phosphoamino acid anal- 
ysis. Figure 2B shows that the immobilized 90-kD nu- 
clear kinase phosphorylated MBP only on serine. Figure 
2C shows that autophosphorylation occurred equally on 
serine and threonine. We conclude that the 90-kD en- 
zyme is a serine-threonine kinase. 
90-kD nuclear kinase activity is stimulated by agents 
that promote cellular proliferation 
We then asked whether the 90-kD nuclear kinase was 
activated by particular signal transduction pathways. To 
Figure 1. Identification ofa 90-kD nuclear kinase. Proteins {50 
wg) from HeLa nuclear and cytosolic extracts were prepared, 
then subjected to SDS-PAGE and renaturation on nitrocellu- 
lose. Renatured autophosphorylation activities are shown, with 
an arrow indicating the 90-kD multiplet. Blots probed with 
[a-32P]ATP showed background radioactivity but no discrete 
bands {data not shown). 
that these various -90 kD polypeptides are differentially 
phosphorylated and, as a result, can be chromatographi- 
cally separated (data not shown; see below). For conve- 
nience of discussion, we will refer to these multiple 
bands as "the 90-kD nuclear kinase". Several other au- 
tophosphorylation activities were detected, but these 
were equally present in nuclear and cytosolic fractions. 
In addition to HeLa cells, we have detected the 90-kD 
nuclear kinase in stimulated human peripheral blood 
lymphocytes (PBLs) and cell lines from humans [A431, 
Jurkat, EBV-transformed human B cell (32D), HUT78, 
and CEM], rodents (MvlLu, 3T3-L1, and CHO), and 
monkeys (CV-1 and COS-7) (data not shown). 
The 90.kD nuclear kinase has a unique specificity 
To determine whether the 90-kD autophosphorylation 
activity could phosphorylate an exogenous protein sub- 
strate, the kinase was partially purified {see below), re- 
solved by SDS-PAGE, transferred to nitrocellulose, and 
renatured. A nitrocellulose strip containing the rena- 
tured kinase was then added to a reaction mixture con- 
taining myelin basic protein (MBP) and [~/-32p]ATP. Fig- 
ure 2A shows that the immobilized 90-kD nuclear ki- 
nase phosphorylated MBP. We then used this assay to 
determine the specificity of the kinase. Of several com- 
mon peptide substrates tested, the 90-kD kinase phos- 
phorylated only peptide substrates for smooth muscle 
myosin light-chain kinase (KKRPQRATSNVFS) and 
cAMP-dependent protein kinase (LRRASLGI (Table 11. 
This pattern distinguishes the 90-kD nuclear kinase 
A B C 
e -pS  
- pT - pS  
:~  - pT 
~ - MBP ,~ 
e l phospho-  peptides 
o ~ - origin - origin 
$ubstrate phosphorylat ion autophos- 
phorylation 
Figure 2. The 90-kD nuclear kinase phosphorylates serine 
and threonine residues. (AI Purified 90-kD nuclear kinase 
was resolved by SDS-PAGE, renatured on nitrocellulose, and 
used to phosphorylate MBP. As a negative control, MBP was 
incubated under the same conditions with nitrocellulose that 
did not have immobilized kinase. Activity was Mg2+-depen - 
dent; Mn 2 + did not substitute (data not shown 1. (B) Phosphoam- 
inoacids of radiolabeled MBP (A,rightl were determined. The 
mobilities of authentic phosphoaminoacid standards are indi- 
cated. (B,leftl MBP phosphorylated with renatured 90-kD 
kinase. (B,right) MBP phosphorylated with a tyrosine kinase 
{recombinant p43V'~b~). {C) Phosphoamino acids of kinase rena- 
tured on a polyvinyldifluoride membrane and autophos- 
phorylated with [~/-32P]ATP. 
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Tab le  1. Peptide substrate specificity of HeLa 90-kD 
nuclear kinase and recombinant RING3 proteins 
Substrate 
RING3 phosphorylated with NE 
HeLa 
(90 kD) WT K578A 
kinase activity (% of Kemptide control) 
Kemptide 100 (---12) 100 (___6) <5 
MLCK 135 (-+7) 51 (___3) <5 
tyrK 11 (-+ 1 ) N.D. N.D. 
S6K 7 (-+1) <5 <S 
CaMKII <5 <5 <5 
MAPK <5 N.D. N.D. 
CKII <5 <5 <5 
PKC <5 N.D. <5 
No substrate <5 <5 <5 
The 90-kD kinase was renatured on nitrocellulose after partial 
purification from HeLa nuclear extract and used to phosphory- 
late peptides with [-y-a2P]ATP. Recombinant proteins were rena- 
tured in polyacrylamide g ls. (WT) Wild type; (K578A) site-di- 
rected point mutant where catalytic Lys578 is changed to ala- 
nine. Phosphate incorporation was linear through at least 60 
rain and 2 mg/ml of peptide. 100% represents -100,000 dpm. 
Peptide substrate sequences are K mptide (cAMP-dependent 
protein kinase), LRRASLG; MLCK (myosin light-chain kinase 
from smooth muscle), KKRPQRATSNVFS; tyrK (tyrosine ki- 
nase), Raytide (an analog of gastrin, EGPWLEEEEEAYG); S6K 
($6 kinase), RRLSSLRA (86 peptide); CaMKII (calmodulin-de- 
pendent kinase II), PLSRTLSVSS; MAPK (microtubule-associ- 
ated protein kinase II), APRTPGGRR; CKII (casein kinase II), 
RRREEETEEE; PKC (protein kinase C), RFARKGSLRQKNV. 
Duplicate assay; (N.D.) not determined. 
determine whether the activity was correlated with cel- 
lular proliferation, a serum-responsive c ll line, A431, 
was starved of serum overnight and then provided with 
20% serum for 15 min. Figure 3A shows that autophos- 
phorylation activity was significantly increased in ex- 
tracts prepared from serum-stimulated cells. In a related 
experiment, PBLs that were normal and quiescent were 
cultured in the presence of phytohemagglutinin (PHA) to 
induce proliferation. Figure 3B shows that the 90-kD nu- 
clear kinase activity was significantly increased in re- 
sponse to PHA. We tested several components of serum 
to determine which, if any, caused this increase. Only 
interleukin-lot (IL-1) treatment resulted in significant 
stimulation {Fig. 3C). Substances that did not increase 
90-kD kinase activity included epidermal growth factor, 
platelet-derived growth factor-B, acidic fibroblast growth 
factor, insulin, glucagon, transforming rowth factor-B, 
and interleukin-2, each of which was tested in an appro- 
priately responsive cell line. Other potential stimuli of 
90-kD autophosphorylation, such as herpesvirus infec- 
tion, heat shock, ultraviolet light, hydrogen peroxide, so- 
dium periodate, sodium vanadate, or cadmium chloride, 
were similarly ineffective (data not shown). Interest- 
ingly, we also found that forskolin, an activator of 
cAMP-dependent protein kinase pathways, transiently 
increased kinase activity in the mammalian T-cell line 
Jurkat {Fig. 3D). 
Autophosphorylation f the 90-kD kinase increased 
sharply -5  min after stimulation in CHO (Fig. 3C) or 
Jurkat (Fig. 3D) cells and declined slightly through 30 
min. The rapid time course suggested that a post-trans- 
lational modification was responsible for the increased 
activity. Consistent with this idea, autophosphorylation 
was dramatically reduced when extracts were prepared 
in the absence of phosphatase inhibitors r were briefly 
warmed to 37°C in the presence of 5 mM magnesium 
chloride (data not shown). These results suggest that the 
90-kD nuclear kinase is reversibly phosphorylated. 
Purification and microsequence analysis of 90-kD 
nuclear kinase 
We purified the kinase from HeLa nuclear extract ac- 
cording to the scheme diagramed in Figure 4A. The par- 
tially purified kinase was resolved by SDS-PAGE, trans- 
ferred to nitrocellulose, and digested with trypsin. Tryp- 
tic peptides were separated by high-pressure liquid 
N 
A °4 /  a 
o ~ o°~ '~" 
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F igure  3. Stimulation of 90-kD autophosphorylation. {A) A431 
ceils were starved of serum, then treated with control buffer or 
calf serum {20%1 for 15 min at 37°C. Kinases innuclear extracts 
were assayed by renaturation assay. An arrow indicates the 90- 
kD multiplet. (B) Total PBLs (~ 1071 were isolated from normal, 
healthy volunteers, uspended in RPMI1640 with 10% autolo- 
gous serum, and cultured for 3 days, either unstimulated or 
stimulated with 2 ~g/ml of PHA. (C1 CHO cells were starved of 
serum, then treated with IL-la {10 ng/ml) for the indicated 
times. (D) Jurkat cells were stimulated with 50 }~M forskolin for 
the indicated times. Stimulated 90-kD kinase activity in Jurkat 
and CHO extracts was enriched by application to phosphocel- 
lulose and elution with 0.3 M NaC1. Increased autophosphory- 
lation was correlated with increased MBP-directed substrate 
phosphorylation (results not shown). 
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Figure 4. Purification and microsequence analysis. (A) Chro- 
matographic s heme. (B) Microsequence Alignment. Homolo- 
gous sequences are indicated with boldface type. Bromo- 
domains are indicated with a heavy solid line. PEST scores are 
indicated in boldface above a broken line that defines a PEST 
sequence (analyzed with the BASICA-supported program PEST- 
FIND). The putative NLS is indicated with a box. Microse- 
quenced peptides are aligned as peptl and pept2. Numbering is 
according to the translated cDNA for fsh. Percent conservation 
of sequence between RING3 and fsh has been reported (Beck et 
al. 1992). 
chromatography (HPLC), and two peptides were mi- 
crosequenced. The first of these (DSNPDEIEIDFE- 
TLKPTTL) was used to probe the GenBank data base; a 
match was obtained to the Drosophila homeotic gene, 
female sterile homeotic (fsh) (DROFSHB) (Haynes et al. 
1989); there were 18 of 19 identities and a conservative T 
to S substitution. A match was also obtained with the 
RING3 gene of humans (HUMRING3) (Beck et al. 1992); 
there were 17 of 19 identities with a conservative D to E 
substitution and the same T to S substitution as in fsh. 
RING3, an acronym for "really "_interesting ew gene", 
was serendipitously discovered uring sequencing of the 
class II region of the human major histocompatibility 
complex (Beck et al. 1992). The second microsequenced 
peptide (AVHEQLAALSQAP) matched RING3; there 
were 12 of 13 identities with a conservative A to G sub- 
stitution at position 12. This peptide did not match fsh. 
Figure 4B presents an alignment of fsh and RING3. The 
calculated molecular mass of RING3 is 83 kD, which 
correlates well with the apparent mobility of the 90-kD 
phosphoprotein asmeasured by SDS-PAGE. 
Immunoprecipitation and immunofluorescence 
analysis 
We performed a series of experiments to test whether 
human RING3 encodes akinase. First, we raised antisera 
to recombinant RING3 and asked whether it could im- 
munoprecipitate 90-kD nuclear kinase activity. Figure 
5A characterizes the affinity-purified aRING3 poly- 
clonal antibody by immunoblot analysis. The results 
show that in a HeLa nuclear extract the aRING3 anti- 
body principally detected a 90-kD polypeptide, whose 
size is consistent with that of the RING3 open reading 
frame (ORF) (Fig. 4B) and the nuclear autophosphoryla- 
tion activity. Two other polypeptides of unknown iden- 
tity were also detected, and, as discussed below, these 
additional polypeptides could be members of a protein 
family. Figure 5B shows the immunopreciPitation a al- 
ysis. Immune complexes were solved by SDS-PAGE, 
and activity was determined by renaturation/autophos- 
phorylation. The results how that the 90-kD kinase was 
immunoprecipitated by the aRING3 antibody but not by 
preimmune serum.  Significantly, the size of the auto- 
phosphorylation activity was identical to that of the ma- 
jor polypeptide detected in the immunoblot experiment 
of Figure 5A. These data strongly support he interpreta- 
A HeLa NE 
I 
reactive green 
I 
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I 
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MICROSEQUENCE 
B 
l0 60 
RING3 ....... MAS VPALQLTPAN PPPPEVSNPK KPGRVTNQLQ Y L H ~  WKHQFAWPFR 
fsh MSSSEPPPRY EPPVEPVNGI  VQPPVIPPAE RPGRNTNQLQ YL IKTVMKVI  WKHHFSWPFQ 
70 bromodomain  I 120 
RING3 QPVDAVKLGL PDYHKI IKQP MDMGTIKRRL  ENNYYWAASE CMQDFNTMFT NCY IYNKPTD 
fsh QPVDAKKLNL  PDYHKI IKQP MDMGTIKKRL  ENNYYWSAEZ T IQDFNTMFN NCYVYNKPGE 
130 150 384 410 
RING3 D IVLMAQTLE K IFLQKVASM PQEEQELVVT . . ,TAAPPAQ PLAKKKGVKR KADTTTPTPT  
fsh DVV%'MAQTLE KVFLQKIESM PKEELELEPV . . .AVIPPQQ PAK IKKGVKR KADTTTPTAN 
11.1 427 491 bromodomain  II 530 
RING3 A ILAPGSP~S PPGSLEP.. .  CNGILKELLS KKHAAYAWPF YKPVDASALG LHDYHDI IKH 
fsh AFESPYTQMD SKSAKIA...  CNEILKELFS KKHSGYAWPF YKPVDAEMLG LHDYHDI IKK  ~.~-"  
540 590 
RING3 PM~DLSTVKRK MENRDYRDAQ EFAADVRLMF SNCYKYNPPD HDVVAMARKL  QDVFEFRYAK 
fsh P~)LGTVKRK MDNREYKSAP EFAADVRLIF  TNCYKYNPPD HDWAMGRKL QDVFEMRYAN 
pept2 595 670 AVHEQLAA LSQAP 690 
RING3 MPDEP. . .EQ LRAVHEQLAA LSQGPISKPK 
fsh IPDEP. . .SK LLGLQEEIRK LSEEASAKKK 
peptl 17.2 960 
RING3 EEEEESRPMS YDEKRQLSLD INKLPGEKLG 
fsh EEEDTAKPMS YDEKRQLSLD INKLPGDKLG 
5.7 
peptl TTL 1020 
RING3 STLRELERYV LSCLRKKPRK PYT IKKPVGK 
fsh STLRELESYV ASCLRKKTRK PYY.KKPSGK 
NLS 938 950 
RKREKKE~--- - - - -~. . .KTA PPALPTGYDS 
AKKKLKEKKK S IGG. . .SKK KPSQVMNFDS 
5.8 DSNPDE IE IDFETLKP 
RVVHI IQARE PSLRDSNPEE IE IDFETLKP 
RVVHI IQNRE PSLRDSNPDE IE IDFETLKP 
5.~" 
1070 
TKEELALEKK RELEKRLQDV SGQLNSTKKP 
SKDEQMAEKK QELEKRLQDV TGQLGASKKT 
1080 iii0 
RING3 PKKANEKTES SSAQQVAVSR LSASSSSSDS SSSSSSSSSS DTSDSDSG 
f~h ~'~DES~S~ _V~3QP_,aP_V_SS3SSSS2S ~ S3SSSD3SSS ~SS2S_~ 9
20.1 
tion that the nuclear autophosphorylation activity re- 
sults from RING3. 
The c~RING3 antibody was also used in the indirect 
immunofluorescence experiment ofFigure 5C. RING3 is 
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phorylation 
clearly nuclear localized, in agreement with the bio- 
chemical fractionation data of Figure 1. We note that the 
R ING30RF contains a putative nuclear localization sig- 
nal (NLS)(see Fig. 4B). 
Figure 5. Immunoblot, immunoprecipitation, andimmunoflu- 
orescence. (A) Immunoblot analysis. HeLa nuclear extract was 
resolved by SDS-PAGE, transferred to nitrocellulose, and im- 
munoblotted with rabbit preimmune serum or purified ~RING3 
antibody. (B) Immunoprecipitation analysis. HeLa nuclear ex- 
tract was immunoprecipitated with rabbit preimmune serum 
(1:50) or e~RING3 antibody (1:50) by recombinant protein 
A-agarose. The immune complexes were resolved by SDS- 
PAGE and assayed for renaturable autophosphorylation activity 
as in Fig. 1. (C) Nuclear immunofluorescence of e~RING3. HeLa 
cells were fixed and incubated with aRING3 antibody. Primary 
antibody was visualized with FITC conjugated to goat antirab- 
bit secondary antibody. RRING3 immunofluorescence colocal- 
ized with 4',6-diamidino-2-phenylindole (DAPI) stain and with 
immunofluorescence from rabbit antibody to TATA box-bind- 
ing protein (~TBP), both of which are authentically nuclear (data 
not shown}. Rabbit preimmune serum did not exhibit signifi- 
cant immunofluorescence (data not shown). 
Recombinant RING3 has kinase activity 
We then asked whether expression of RING3 cDNA in 
bacteria nd mammal ian cells gave rise to a protein with 
kinase activity. For bacterial expression, RING3 was 
tagged with six histidines at the amino terminus, ex- 
pressed in Escherichia coli. and purified to homogeneity 
by Ni +-agarose chromatography (Fig. 6A; B, Coomassie, 
WT). Figure 6B {lane 2) shows that this E. coli-derived 
protein lacked kinase activity. In several other cases, re- 
combinant kinases are inactive in the absence of specific 
post-translational phosphorylation (e.g., see Wil l iams et 
al. 1992; Kozma et al. 1993). Therefore, we incubated the 
E. coli-derived RING3 with HeLa nuclear extract and 
ATP and repurified it according to the scheme shown i
Figure 6A, which included a stringent 6 M guanidine hy- 
drochloride wash of the Ni + column to remove any con- 
taminating kinase activities (see Fig. 6B, lanes 1,8). The 
modified recombinant protein now possessed kinase ac- 
tivity (Fig. 6B, lane 3); as expected, this modification was 
ATP dependent (Fig. 6B, lane 8). These results also imply 
the existence of a RING3-activating kinase in HeLa nu- 
clear extract. 
To provide further evidence that the observed kinase 
activity was from recombinant RING3, we constructed 
two RING3 carboxy-terminal deletion mutants (Fig. 6B, 
bottom). The first deletion removed apolyserine tail (see 
Fig. 4B), which slightly reduced its size (Fig. 6B, 
Coomassie, &SnaBI), but did not abolish kinase activity 
(Fig. 6B, lane 5). The reduced size of the autophosphory- 
lation activity observed with the &SnaBI mutant 
strongly argues that recombinant RING3 is the kinase. 
(Like wild-type RING3, the unmodified &SnaBI protein 
lacked kinase activity; Fig. 6B, lane 4.) A more extensive 
deletion (&BspMI), which removed a putative catalytic 
glutamate (see below), abolished kinase activity (Fig. 6B, 
lane 6). 
To confirm that recombinant RING3 possessed the 
same specificity as the HeLa 90-kD nuclear kinase, we 
compared the ability of the two enzymes to phosphory- 
late peptide substrates. Table 1 shows that, like the HeLa 
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Figure 6. Autophosphorylation activity of recombinant wild-type and mutant RING3 derivatives. {A) Purification of recombinant 
RING3. {B) Activity of recombinant RING3. Bacterially expressed wil type {WT) and two deletion mutants {ASnaBI and ABspMI) of 
histidine-tagged RING3 were visualized by Coomassie stain and assayed by in-gel kinase assay. (Lane 1) NE incubated with ATP in 
the absence of recombinant enzyme, then processed (A) as a negative control (column control); {lane 2) unmodified WT enzyme; (lane 
3) WT enzyme after modification with NE and ATP; {lane 4) unmodified ASnaBI enzyme; (lane 5} ASnaBI enzyme after modification; 
(lane 6) ABspMI enzyme after modification; {lane 7) positive control f r NE alone; (lane 8)WT enzyme after modification with NE in 
the absence of ATP. 
90-kD nuclear kinase, RING3 phosphorylated only pep- 
tide substrates for both cAMP-dependent protein kinase 
(Kemptide) and smooth muscle myosin light-chain ki- 
nase. Finally, we used site-directed mutagenesis to 
change a putative catalytic lysine (see below) to alanine 
(K578A). When expressed as a histidine-tagged protein 
and modified as above, this RING3 amino acid substitu- 
tion mutant was unable to phosphorylate any of these 
peptides (Table 1). 
For mammalian overexpression, COS cells were tran- 
siently transfected with a CMV vector that directed ex- 
pression of RING3 cDNA (CMV-RING3). Nuclear ex- 
tracts were prepared from these transfected cells and 
fractionated by phosphocellulose chromatography, 
which we found could resolve ectopically expressed from 
endogenous kinase activity {Fig. 7; data not shown). Fig- 
ure 7 shows that 90-kD nuclear kinase activity was 
greatly increased in COS cells transfected with CMV- 
RING3. These data and those of Figures 5, B and C, 6B, 
and Table 1 indicate that RING3 is a nuclear kinase. 
Potential relevance to leukemia 
The stimulation of 90-kD autophosphorylation activity 
by serum [Fig. 3A) and mitogenic lectins {Fig. 3B) sug- 
gested a relationship with cellular proliferation. Further- 
more, as discussed below, several pieces of evidence sug- 
gested that RING3 may be in a signal transduction path- 
way involved in human leukemias. To test whether 
there is an association between 90-kD kinase activity 
and leukemic proliferation, PBLs from normal individu- 
als were compared with an equivalent number of PBLs 
from individuals with chronic lymphocytic leukemia 
{CLL) or acute lymphocytic leukemia {ALL}. Figure 8A 
shows that leukemic PBLs {blasts or mature T cells) had 
very high levels of 90-kD autophosphorylation activity 
kDa 
/ 
101 - -  
71- -  
44 - -  
; ,  ~ ~, t  ~ 
Figure 7. Mammalian expression of 90-kD nuclear kinase ac- 
tivity from RING3 cDNA. COS cells were transfected by cal- 
cium phosphate and harvested 48 hr later. Nuclear extracts 
were applied to phosphocellulose and eluted with 0.2 M NaC1, 
which separated ectopically expressed activity from endoge- 
nous activity. Transfections were with empty vector (CMVI or 
with vector containing RING3 cDNA (CMV-RING31. An arrow 
indicates the 90-kD multiplet. 
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A 
kDa 
101 - -  
71 - -  
44- -  
28.3 --  
/ B 
Renatured cell extracts Renatured ~RING3 
immune complexes 
Figure 8. Elevated 90-kD nuclear kinase activity in acute and 
chronic leukemic ells. (A) Cell extracts were prepared from 10 z 
PBLs. Proteins were separated by SDS-PAGE, renatured, and 
autophosphorylated. (Normal PBL) Normal 34-year-old male; 
[CLL) 69-year-old male diagnosed with chronic lymphocytic 
leukemia (> 10 6 mature T cells/~l, lymphostasis, mmune sup- 
pression); (ALL) 4-year-old female diagnosed with acute lym- 
phocytic leukemia in proliferative blast stage; (ALL) 15-year-old 
male with same diagnosis; (ALL remission) same 15-year-old 
male after chemotherapy. Results were representative for 10 
normal controls and 10 ALL patients (>5 x 10 4 blasts/~l in 
each case). Immunoblot with e~RING3 confirmed no significant 
differences in 90-kD protein expression between ALL cases and 
controls (results not shown). (B) Two PBL extracts from A were 
immunoprecipitated with e~RING3 antibody. Immune com- 
plexes were washed, solubilized with SDS, and assayed as in A.
The 90-kD kinase activity is indicated by an arrow. 
compared with normal PBLs. Interestingly, there was a 
renaturable autophosphorylation activity of -50  kD that 
was prominent only in normal PBLs. One of the ALL 
patients entered remission after chemotherapy, and the 
same number of PBLs were assayed again. In this case 
(ALL remission), the 90-kD autophosphorylation signal 
was comparable with normal controls. 
To confirm that the increased 90-kD autophosphory- 
lation activity in leukemic cells was related to RING3, 
we performed an immunoprecipitation experiment. 
aRING3 immune complexes were resolved by SDS- 
PAGE and assayed by renaturation and autophosphory- 
lation. Autophosphorylation (90 kD) was recovered only 
from leukemic PBLs (Fig. 8B). Taken together, these data 
reveal a correlation between 90-kD autophosphorylation 
activity and leukemia. 
Discussion 
We sought o identify nuclear kinases that might be im- 
portant in signal transduction and growth control. We 
found a novel, renaturable kinase of an apparent molec- 
ular mass of 90 kD. Three lines of evidence indicate that 
the kinase is encoded by human gene RING3: First, two 
microsequenced peptides of the purified 90-kD nuclear 
kinase matched RING3 in the GenBank data base (Fig. 
4B); second, antibody raised against recombinant RING3 
specifically immunoprecipitated the 90-kD nuclear ki- 
nase (Fig. 5B); and third, RING3 eDNA encoded 90-kD 
autophosphorylation a d transphosphorylation activi- 
ties with properties imilar to the native enzyme (Figs. 
6B and 7; Table 1). 
RING3 is a nonconsensus  k inase  
Tryptic peptides of the purified kinase were highly ho- 
mologous to two proteins that share regions of homol- 
ogy: fsh and RINGa. While this manuscript was in prep- 
aration, we reprobed the GenBank data base with the 
two peptide sequences and found a new match to an 
unpublished open reading frame, accession number 
D26362, that is highly homologous to RING3. These re- 
sults suggest hat the 90-kD kinase may be part of a 
protein family. There was no prior information regarding 
the cellular localization, biochemical activity, or expres- 
sion of these proteins. For convenience of discussion, we 
will refer to the mammalian proteins as "RING3 ki- 
nase." The homologous regions of fsh, RINGa, and 
D26362 include kinase motifs (see below}, bromo- 
domains (found in certain regulatory genes; Haynes et al. 
1992; Tamkun et al. 1992), and PEST sequences (linked 
to high turnover rates; Dice 1987; Rechsteiner et al. 
1987; Rechsteiner 1988, 1990; Chevaillier 1993)(Fig. 4B). 
Most protein kinases conform to a consensus compris- 
ing a set of relatively short amino acid motifs (Hunter 
1987). RING3 and fsh appear to deviate from this con- 
sensus, which explains in part why these proteins were 
not previously suspected to be kinases. Whereas certain 
kinases, for example, p160 ¢BcR (Maru and Witte 1991) 
lack the canonical serine/threonine s quence motifs, 
careful inspection of RING3 reveals the presence of con- 
sensus kinase motifs that appear to be "out of order" 
(Fig. 9). For example, RING3 contains a putative ATP 
binding motif (GXGXXG; subdomain I; Hanks et al. 
1988; Hanks 1991) at amino acid 558 and a putative cat- 
alytic lysine (AXK; subdomain II) at amino acid 578 (Fig- 
ure 9). When compared with a data base of all kinases, 
these sequences and spacing are most similar to the cor- 
responding subdomains of c -mos .  A putative subdomain 
III, which contains a catalytic glutamate at amino acid 
605, is not closely related to c -mos  but falls into a dif- 
ferent class of kinases characterized by an EKR motif at 
that position. Therefore, RING3 is not a close relative of 
any existing protein kinase. Other putative subdomains, 
for example, kinase consensus sequences YHRDLK {sub- 
domain VIB) and APE (subdomain VIII} (Hanks et al. 
1988; Hanks 1991), are found in the expected order in 
two amino-terminal domains of both RING3 and fsh. 
Kinases with multiple catalytic domains (Jones et al. 
1988; Banerjee et al. 1990) or mosaics of serine/threo- 
nine and tyrosine kinase subdomains (Levin et al. 1987) 
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have been described. We conclude that RING3 defines a 
new class of kinase, possessing several serine/threonine 
kinase motifs, but with rearranged subdomains. 
There are several precedents for enzymes with "scram- 
bled" primary sequence motifs. For example, lipases, 
serine proteases, and cholinesterases mploy a similar 
VIA VIB 
34 48 66 ~6 
consensus yoo.o...o.ooh,o yhrdlk..ncc 
RING3 YLHKVVMKALW~QF RING3 Y~K~I~P~DM 
fsh YLIKTVMKVIWK~HF fsh Y I M 
dckii YLFELLKALDYC~SM ranl Y • IM 
c-mos YSLDVVNGLLFL~SQ weel ).~ 
camii -a C IQQI LEAVLHC~QM pkc-a I ~ L ~ i  
cdc7 YIWELLRALKFV~SK zmpkl I[~C~V~PE~IL 
XX VIA (2) 
109 124 310 324 
consensus ynk ..... dow+og..ooe o.. .o.. .o.ooh.o 
RING3 YNK..PTD~IVLM~TL~ RING3 CNGILKELLSK I~A 
fsh YNK..PGF~]VVVM~TL~_ fsh CNEILKELFSKK~SG 
ecapk  YNK. . .AV~WA~LIY~ c-mos YSLDVVNGLLF~SQ 
tpkl YNK..,SI~IdWSF~LIY~ c~u~ii-a CIQQILEAVLHC~QM 
pkc-z YGF. . .SV~CWA~LMF~ ecapk YAAQIVLAFEY~$L  
stk YNRFT IKS~/WSF~IL~ arkl I INGIARGLLYL~QD 
VIB (2) VIII IX (2) 
343 353 365 371 385 401 
consensus yhrdlk., noo y.. apeo ynk ..... dow+og., ooe 
RIaG3 Y~HI~P~L RI.G) YRD~IilZ RI.G3 YNP..PD~VV~KLQ 
fsh Y~HI~P~L fsh YKS~ fsh YNP.. P D H~VVAM~K LQ 
weel V~L~L~PA~IVM pkc-a Y I .~ I  tpkl YNK.. .SI~WWSF~ILIY 
gsk3a C~I~Q~L ckiia YFK~L stk YNRFT IK~]VWSF~ LMA 
pkc-a I~R,~G~LD~M pskgl HYR~ pkc-z YGF. . .S%~WWAL~LMF 
I I7  7I I  
557 578 602 609 
consensus ig.g.og.v . . . . . . . . . . . .  aok to.ekroc 
RI.G3 ~_~. .~s~~ ai.~3 s~,~Q~ 
f sh  A~A~V~G~. .  GGAGAAGGGN~ f sh  S Y D~]~KRQ L 
c-mos L~A~S~. .  YKATYRGVP~I~ tpk2 TND~RML 
pkc-m L~K~MLADRKGTEEL~I~ capk-a TLN~RI  e 
tpkl L~T ~S 5~R~dL IR S RHNGRY Y~M~ npkc-e TMT~RI  L 
ecapk L~T~S ~R~MLVK H KQ S GN Y Y~4~ ecapk TLNL~KRI L 
Figure 9. Comparison ot putative subdomains of RING3 and 
fsh with known protein kinases. The authentic subdomains of 
known kinases are compared with fsh and RING3; the closest 
overall resemblances were with kinases of the cAMP-dependent 
protein kinase and protein kinase C families. For comparison, 
some kinases with unusual subdomain sequences are included. 
Numbering corresponds to the translated RING3 eDNA se- 
quence. Conserved amino acids are identified above the RING3 
sequence by lowercase letter. The most highly conserved amino 
acids are identified by a solid black box with white type. Hy- 
drophobic amino acids (F, Y, L, V, W) are referred to as a class 
with an o, small side chain (A, S, T) with a +, and no consensus 
with a period. Where RING3 appears twice, internally dupli- 
cated domains are compared. The Hanks subdomains that are 
not obviously present in RING3 are IV, V, VII, and the con- 
served arginine of XI. (arkl)Arabidopsis thaliana receptor ki- 
nase; (camii-a) rat calcium/calmodulin-dependent protein ki- 
nase II-a; (capk-a) human cAMP-dependent protein kinase a; 
(cdc7) Saccharomyces cerevisiae w ld-type CDC7; (ckiia) hu- 
man casein kinase II-a; (c-mos) human cellular homolog of 
v-mos; (dckii) Drosophila melanogaster casein kinase II-a; 
(ecapk) Caenorhabditis elegans cAMP-dependent protein ki- 
nase c; (gsk3a) glycogen synthase kinase 3; (npkc-el mouse pro- 
tein kinase C-like protein; (pkc-a) rat protein kinase C-a; (pkc-z) 
rat protein kinase C-~; (pskgl) human putative protein-serine 
kinase; (ranl) Schizosaccharomyces pornbe wild-type "meiotic 
bypass" protein; (stk) hydra src-related protein; (tpkl) S. cerevi- 
siae cAMP-dependent protein kinase type 1; (tpk2) S. cerevisiae 
cAMP-dependent protein kinase type 2; (weel) S. pombe wild- 
type "reduced size at division" protein; (zmpkl) maize receptor 
protein kinase. 
catalytic triad of serine, histidine, and aspartate/gluta- 
mate in a conserved three-dimensional arrangement, but 
the individual members of the triad can be located on 
different loops or even on c~-carbon backbones of oppo- 
site direction (Schrag et al. 1991; Dodson et al. 1992). 
Role of RING3 in development and leukemogenesis 
The physiological substrates of RING3 kinase are un- 
known, but in light of its nuclear location and respon- 
siveness to mitogenic signals, transcription factors are 
likely targets. Sequence homology strongly suggests that 
fsh, a Drosophila homeotic gene product that is highly 
related to RING3, is also a kinase (Figs. 4B and 9). Ge- 
netic studies in Drosophila suggest hat fsh is a trans- 
acting effector of trithorax, another homeotic gene (Di- 
gan et al. 1986; Mozer and Dawid 1989; Breen and Harte 
1991, 1993). For example, reduced levels of fsh can in- 
crease the severity of trithorax mutations (Gans et al. 
1980; Forquignon 1981). The sequence of trithorax 
strongly suggests that it is a transcription factor (Mazo et 
el. 1990). On the basis of these considerations, we hy- 
pothesize that fsh activates trithorax through phospho- 
rylation, and that these two proteins are components of 
a signal transduction pathway involved in Drosophila 
development. 
A human homolog of trithorax has been identified and 
referred to as ALL-1 (also called HRX, MLL, and HTRX- 
1; Cimino et al. 1991; Djabali et al. 1992; Gu et al. 1992; 
Tkachuk et al. 1992; Ford et al. 1993). In certain leuke- 
mias, the gene encoding ALL-1 is interrupted by a recip- 
rocal chromosomal translocation that results in an 
ALL-1 fusion protein, whose functional properties are 
presumably altered. In several other instances, human 
homologs of Drosophila homeotic genes are rearranged 
in leukemic cells: An 8q22 translocation associated with 
acute myelogenous leukemia interrupts a gene with ho- 
mology to runt (Miyoshi et al. 1993), an 1 lq23 translo- 
cation associated with acute promyelogenous leukemia 
involves a gene with a Krfippel-like zinc finger {Chen et 
al. 1993), and an 11q23 translocation associated with 
T-lymphoblastic leukemia interrupts TAN-l, a human 
homolog of notch (Ellisen et al. 1991). 
Intriguingly, our results have revealed a relationship 
between RING3 kinase activity and lymphocytic leuke- 
mia. These new data, in conjunction with previous tud- 
ies on ALL-l, suggest hat RING3 and ALL-1 are com- 
ponents of a signal transduction pathway that becomes 
deregulated in certain leukemias. The availability, for 
the first time, of an assayable biochemical activity for a 
component of this putative signal transduction pathway 
will facilitate more detailed study. Further analysis of 
the functional relationship between fsh and trithorax 
and between RING3 and ALL-1 will help illuminate the 
role of nuclear kinase activity in development, growth 
control, and leukemogenesis. 
Materials and methods 
Autophosphorylation assay 
Extracts were prepared (Dignam et al. 1983) in the presence of 
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sodium vanadate (1 mM) and B-glycerolphosphate (50mM) and 
centrifuged ( 100,000g, 60 rain at 4°C) to remove particulate mat- 
ter. The proteins in the supernatants were separated by SDS- 
PAGE (Laemmli 1970), electroblotted to nitrocellulose or poly- 
vinyldifluoride membranes, denatured, renatured, probed with 
[~/-a2P]ATP for autophosphorylation (Ferrell and Martin 1989), 
and subjected to autoradiography. 
In vitro phosphorylation 
Synthetic peptides were incubated at 30°C for 1 hr in 10-~1 
reactions containing 30 mM MgC12, 30 mM HEPES {pH 8.0), 2 
mM DTT, 0.5 mM EDTA, 0.1% NP-40, 10 ~M ATP, 0.15 mCi/ 
ml of [~/-32P]ATP, and 1 mg/ml of peptide. Reaction mixtures 
were quenched with ice-cold 10% phosphoric acid and applied 
to 0.1-ml phosphocellulose columns or P-81 paper circles 
{Whatman}, which were washed extensively with 0.5% phos- 
phoric acid. Incorporation of32p into peptide (-  100,000 dpm for 
Kemptide) was determined for duplicate reactions by Cerenkov 
counting. {Raytide and p43 v-abl were from Oncogene Science.) 
For MBP phosphorylation, reactions contained 1mg/ml of pro- 
tein and were quenched with SDS sample buffer. Radiolabeled 
MBP was resolved by PAGE and visualized by autoradiography. 
Phosphoaminoacids were determined (Cooper et al. 1983; Lewis 
et al. 1990}. 
Kinase purification 
HeLa nuclear extract (100 ml) was applied to a column of reac- 
tive green-19 resin (40-ml bed volume, equilibrated with buffer 
A {20 mM Tris at pH 7.0, 50 mM NaC1, 50 mM B-glycerolphos- 
phate, 10% glycerol, 1 mM Na vanadate, 1 mM DTT, 0.2 mM 
EDTA, 0.02% NAN3, and 0.1% NP-40). All steps were con- 
ducted on ice or at 4°C. The flowthrough was discarded, and the 
column was washed extensively with buffer A and then eluted 
in batch with buffer B (buffer A supplemented with 20 rnM di- 
sodium ATP, 20 mM EDTA, and 0.5 M NaC1, at pH 7.0). Am- 
monium sulfate was gradually added to the eluate to 50% (wt/ 
vol) over 60 min at 4°C, whereupon the suspension was centri- 
fuged (lO, O00g, 45 min at 4°C). The pellet was recovered, 
dissolved in buffer C (buffer A supplemented with 10 mM 
MnC12, pH 8.0), and desalted on Sephadex G-25 that had been 
equilibrated with buffer C. The desalted protein was applied to 
a column of Cibacron blue 3GA agarose (type 3000) that had 
been equilibrated with buffer C. The flowthrough was dis- 
carded; the column was washed extensively with buffer C and 
eluted in batch with buffer D (buffer A supplemented with 20 
mM EDTA and 0.15 M NaCI, at pH 8.0). The eluate was diluted 
1:1 with buffer E (buffer A with no NaC1, at pH 8.0) and applied 
to phosphocellulose that had been equilibrated with buffer F 
(buffer A at pH 8.0). The phosphocellulose was washed exten- 
sively and eluted in batch with 0.6 M NaC1 in buffer F. The 
eluate was precipitated with trichloroacetic acid (10% final), 
washed with acetone, and solubilized in SDS sample buffer. 
Proteins were resolved by SDS-PAGE in 8% polyacrylamide, 
blotted to nitrocellulose, and visualized with Ponceau S. The 
band corresponding to the autophosphorylation activity of the 
90-kD kinase was excised and igested with trypsin. Tryptic 
peptides were resolved by HPLC and microsequenced. 
Plasmid constructs and antibody production 
RING3 cDNA (clone GEM32, a 4-kb insert in CDMS; Beck et al. 
1992) was propagated in MC1061/P3 (Invitrogen). A 1426-bp 
NcoI-EcoRI fragment (nucleotides 2214-3640) of RING3 was 
ligated into pGEX-2T for bacterial overexpression {Lin and 
Green 1991). Rabbit polyclonal antibody was raised against pu- 
rified glutathionine S-transferase {GST) fusion protein. For pro- 
duction of purified antibody, rabbit immune sera were incu- 
bated with GST-agarose to remove antibodies against GST 
epitopes. Polyclonal antibodies against RING3 epitopes were 
then purified by antigen affinity chromatography onAffigel col- 
umns that contained the purified GST fusion protein. 
For construction of a eukaryotic overexpression vector, the 
full-length RING3 coding sequence was obtained by double- 
stranded polymerase chain reaction (PCR) amplification of 
clone CEM32 with a forward primer (5'-CGCCGCGGATC- 
CATGGCTTCGGTGCCTGCT-3') that engineered a 5' BamHI 
site at the amino-terminal methionine of the coding sequence 
(nucleotide 1178) and a reverse primer (5'-GGCTGGGAAT- 
TCAATGTF-3') that was complementary to the native EcoRI 
site in the 3'-untranslated region (nucleotide 3640). The 2467-bp 
BamHI-EcoRI fragment from PCR was ligated into pcDNA{I) 
(Invitrogen). For bacterial overexpression, this fragment was li- 
gated into RSETA (Invitrogen), which fused six histidines to the 
amino terminus of RING3. 
Deletion mutants and site-directed mutagenesis 
Deletion mutants of RING3 were constructed as follows: a 481- 
bp SnaBI-EcoRI fragment hat encodes a polyserine tail was 
removed from the carboxyl terminus (nucleotides 3156--3640, 
hSnaBI). A 597-bp internal BspMI-BspMI fragment that encodes 
a putative catalytic glutamate {nucleotide 2972, E605) in addi- 
tion to the polyserine tail (nucleotides 2914-3505, ABspMI) was 
removed. Overhanging ends were then filled-in with DNA poly- 
merase I (Klenow), and the vector was religated blunt. 
A site-directed mutant of RING3 was constructed from a 
1508-bp SphI-EcoRI fragment (nucleotides 2128-3640) that 
contains the codon for a putative catalytic lysine (nucleotide 
2897, K578). This fragment was subcloned into M13 mpl8 and 
mutagenized (Kunkel 1985) with an oligonucleotide, 5'-CC- 
CAAAAAGGCCACAGCGAC__GGGCCCCACCTGCC-3' , where 
G__CCG (alanine) replaced AAG {lysine) and ACG is a silent site 
replacement ofAC__C. A 391-bp EspI-EspI fragment {nucleotides 
2592-2983) of the M13 RF DNA was used to shuttle the mu- 
tated site [K578A) back into RSETA for overexpression of the 
full-length mutant protein. All clones were verified by dideoxy 
sequencing. 
HeLa NE modification of RING3 
Histidine-tagged recombinant protein was purified on Ni +-aga- 
rose (Qiagen), and phosphorylated by incubation for 30 rain at 
30°C with HeLa nuclear extract in buffer A that contained 10 
mM ATP, 5 mM MgC12, and protease inhibitors but no Na van- 
adate. As a negative control for ATP-dependent modification, 
HeLa NE was incubated with 460 U/ml of hexokinase and 250 
mM D-glucose (25°C for 30 rain) to deplete ATP before recom- 
binant protein was added. Phosphorylated protein was repuri- 
fled on Ni+-agarose and assayed by in-gel kinase assay (Gotoh 
et al. 1990). 
Sequence analysis 
Sequence data b ses were scanned with BLAST (Altschul et al. 
1993) and Intelligenetics software. Putative subdomains of 
RING3 and fsh were aligned to a data base of the catalytic do- 
mains of all known protein kinases (quinn@salk-sc2.sdsc.edu). 
Separate alignments were performed for each subdomain and 
were optimized by visual inspection. 
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